To find out if your medication or diagnosis is covered by HealthWell, and under which specific Disease Fund, please enter a medication name, disease name, or diagnosis code
Approximately 85% of patients with diabetes mellitus have Type 2 diabetes mellitus (T2DM), which can be a result of genetic predisposition, environmental factors, or a combination of these two [4]
Most practitioners reported following current ASA nothing by mouth (NPO) guidelines for patients taking GLP-1 agonists
Overall, GLP-1 receptor agonists are not replacements for existing treatments such as naltrexone in alcohol use disorder
Per week: 2 swabs 8 weeks: 16 swabs 12 weeks: 24 swabs 16 weeks: 32 swabs 20 weeks: 40 swabs recommend 1 100-count box Protocol Overview Concise summary of the once-weekly regimen
Patients should maintain regular contact with their diabetes care team and report any concerns about hypoglycaemia, particularly if taking GLP-1 medications alongside other glucose-lowering agents such as sulphonylureas or insulin